𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: A strategy of extensive lesion coverage with drug-eluting stents

✍ Scribed by Gerald S. Werner; Gero Schwarz; Dirk Prochnau; Michael Fritzenwanger; Andreas Krack; Stefan Betge; Hans R. Figulla

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
275 KB
Volume
67
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel paclitaxel-eluting, biodegradable
Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: A prospective multicenter registry
✍ Paweł Buszman; Stanisław Trznadel; Krzysztof Milewski; Janusz Rzeźniczak; Tadeus 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract Objectives: The purpose of the present study was to evaluate the efficacy and safety of a biodegradable polymer coated, paclitaxel eluting stent (Luc‐Chopin^2^) based on 9‐months angiographic and 12‐months clinical follow‐up results. Background: First‐generation drug‐eluting stents util

ISR II study: A long-term evaluation of
ISR II study: A long-term evaluation of sirolimus-eluting stent in the treatment of patients with in-stent restenotic native coronary artery lesions
✍ Philippe Commeau; Paul T. Barragan; Pierre O. Roquebert; Jean B. Siméoni 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

The aim of this pilot study was to determine the safety and long-term efficacy of treating intrastent restenosis (ISR) with the slow-release sirolimus-eluting stent Bx Velocity (Cypher stent) without intravascular ultrasound (IVUS) guidance. Of patients who received a bare metal stent implantation a